Virtual CME Program
1.00 CME/CE Credit
Curbside Consults: Top Questions from PCPs on Supplements and Acute Pancreatitis
The world of supplements is expanding at an exponential pace and remains an unregulated and highly profitable industry. Learn strategies for navigating the complex conversation around vitamins, herbs, and supplements in a busy primary care setting while still offering holistic and patient-centered approaches to health.
Management of acute pancreatitis is critical to prevent local and systemic complications of disease. In this session, expert faculty prepare clinicians to recognize pancreatitis severity and ensure proper management of acute pancreatitis.
CME/CE Information
1.00 AMA PRA Category 1 Credits™, 1.00 ABIM MOC or 1.00 AANP, including 0.60 AANP Pharm
Release Date: 7/24/2024
Expiration Date: 9/24/2025
Learning Objectives
- Identify ways to empower patients to understand and navigate the complexities of dietary supplement use
- Develop strategies to address patients’ use of complementary and alternative medicine
- Share resources to guide evidence-informed integrative care
- Discuss an overview of the diagnosis, etiologies, and clinical and radiological features of severity in pancreatitis
- Summarize the inpatient management of acute pancreatitis and how to monitor patients for long-term complications from pancreatitis
Faculty
Meroë B. Morse, MD, ABOIM
Assistant Professor of Medicine
Section of Integrative Medicine
Department of Palliative, Rehabilitation, and Integrative Medicine
MD Anderson Cancer Center
Houston, TX
Yasmin Hernandez-Barco
Director of the MGH Pancreas Program
Director of the NPF designated National Center of Excellence for Pancreatitis
Outpatient Director, Pancreatitis Treatment Program
Instructor of Medicine, Harvard Medical School
Massachusetts General Hospital | Division of Gastroenterology
Boston, MA
Disclosures
The following relevant financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute.
Meroë B. Morse, MD, ABoIM: No relevant financial relationships disclosed.
Yasmin Hernandez-Barco, MD: Advisor for Nestle Health Science and Amgen.
Charles Vega, MD (Moderator): Consultant for Boehringer Ingelheim.
Non-faculty contributors and others involved in the planning, development, editing, and review of the content have disclosed no relevant financial relationships.
CME/CE Information
AMA PRA Category 1 Credits™
Accreditation Statement
Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement
Pri-Med Institute designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AANP
Accreditation Statement
Pri-Med Institute is accredited by the American Association of Nurse Practitioners® as an approved provider of nurse practitioner continuing education. Provider number: 040308.
Designation Statement
This activity is approved for 1.00 contact hour of continuing education, which includes 0.60 hours of pharmacology.
MOC Credit Information
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Instructions for Obtaining Credit
Fine Print
The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.
The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed by, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, DBC Pri-Med, LLC.
Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.
Pri-Med Institute educational activities are developed and conducted in accordance with the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. It is the mission of Pri-Med Institute to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.
Pri-Med Institute Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP.
Disclosures and Conflict of Interest
Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME/CE activities to disclose personal financial relationships with commercial interests or ineligible companies prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to mitigate real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. All relevant financial relationships have been mitigated Financial disclosures for everyone in control of educational content are provided before the start of each CME/CE activity.
Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.
Questions?
If you have questions about this activity, please email support@pri-med.com or call (877) 477-4633.